Devises / GUTS
GUTS: Fractyl Health Inc
0.97
USD
0.02
(2.02%)
Le taux de change de GUTS a changé de -2.02% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 0.96 et à un maximum de 1.00.
Suivez la dynamique Fractyl Health Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GUTS Nouvelles
- This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - CoreWeave (NASDAQ:CRWV), Biomea Fusion (NASDAQ:BMEA)
- Canaccord Genuity lowers Fractyl Health stock price target to $6 from $12
- Fractyl Health raises $23 million in public offering with warrants
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19%
- Nasdaq Surges 1%; Uber Sales Top Estimates - Ainos (NASDAQ:AIMD), Astera Labs (NASDAQ:ALAB)
- Fractyl Health stock plunges after $20 million public offering
- US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Ainos (NASDAQ:AIMD), Fractyl Health (NASDAQ:GUTS)
- Fractyl Health prices $20 million public offering of common stock
- Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Astera Labs (NASDAQ:ALAB), Digital Turbine (NASDAQ:APPS)
- Fractyl Health announces proposed public offering of common stock
- Fractyl’s Revita procedure shows durable weight loss in diabetes patients
- Canaccord Genuity reiterates Buy rating on Fractyl Health stock
- Fractyl Health: Speculative Buy With Binary Risk (NASDAQ:GUTS)
- Fractyl Health stock maintains Buy rating at Canaccord on positive trial data
- Fractyl Health Stock Is Trading Lower Monday: What's Going On? - Fractyl Health (NASDAQ:GUTS)
- Fractyl Health stock steady as Evercore ISI reiterates outperform rating
- Fractyl reports positive 3-month data for post-GLP-1 weight maintenance
- Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type
- Fractyl Health receives two new patents for duodenal resurfacing tech
- Fractyl Health to Present New Preclinical Data from its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association’s 85th Scientific Sessions
- Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita ® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
- Fractyl Health advances gene therapy for diabetes treatment
- Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
- Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript
Range quotidien
0.96
1.00
Range Annuel
0.87
3.67
- Clôture Précédente
- 0.99
- Ouverture
- 0.99
- Bid
- 0.97
- Ask
- 1.27
- Plus Bas
- 0.96
- Plus Haut
- 1.00
- Volume
- 510
- Changement quotidien
- -2.02%
- Changement Mensuel
- -47.28%
- Changement à 6 Mois
- -39.38%
- Changement Annuel
- -71.80%
31 août, dimanche